Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Company Profile: Celgene Corporation

Dec. 30, 1996

Novel antihistamine formulation approved by FDA

Dec. 24, 1996

NanoSystems to develop novel formulation of HIV protease inhibitor

Dec. 23, 1996

First Rx for oral ulcers cleared by FDA

Dec. 23, 1996

Schering-Plough claims novel use for Flt3 ligand

Dec. 23, 1996

Takeda claims new treatments for pancreatitis

Dec. 23, 1996

Regeneron claims novel use for neurotrophic factor

Dec. 23, 1996

Spray formulation of antimigraine Rx cleared for marketing

Dec. 20, 1996

Advisory committee recommends approval of non-nicotine smoking cessation product

Dec. 13, 1996

First marketing approval for Allergan antipsoriatic

Dec. 13, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...